Vetoquinol (VETO) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.026x

Based on the latest financial reports, Vetoquinol (VETO) has a cash flow conversion efficiency ratio of 0.026x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€14.72 Million ≈ $17.21 Million USD) by net assets (€567.53 Million ≈ $663.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review Vetoquinol free cash flow to debt ratio to assess the company's free cash flow relative to its total liabilities.

Vetoquinol - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Vetoquinol's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see market cap of Vetoquinol for the company's overall valuation and market capitalisation.

Vetoquinol Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vetoquinol ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Foxsemicon Integrated Technology Inc
TW:3413
0.038x
Changjiang & Jinggong Steel Building Group Co Ltd
SHG:600496
0.037x
Nanjing Xinlian Electronics Co Ltd
SHE:002546
0.029x
Miracle Automation Engineering
SHE:002009
0.008x
Retail Estates - Sicafi
BR:RET
0.026x
Hunan Er Kang Pharmaceutical
SHE:300267
0.040x
WAVE LIFE SCIENCES LTD.
F:1U5
-0.116x
Top Energy Shanxi Co Ltd
SHG:600780
0.054x

Annual Cash Flow Conversion Efficiency for Vetoquinol (2004–2024)

The table below shows the annual cash flow conversion efficiency of Vetoquinol from 2004 to 2024. View Vetoquinol stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €575.93 Million
≈ $673.33 Million
€85.83 Million
≈ $100.34 Million
0.149x -12.13%
2023-12-31 €527.11 Million
≈ $616.25 Million
€89.39 Million
≈ $104.51 Million
0.170x +30.77%
2022-12-31 €484.66 Million
≈ $566.62 Million
€62.85 Million
≈ $73.48 Million
0.130x -36.20%
2021-12-31 €441.35 Million
≈ $515.99 Million
€89.72 Million
≈ $104.89 Million
0.203x -18.05%
2020-12-31 €371.83 Million
≈ $434.71 Million
€92.23 Million
≈ $107.83 Million
0.248x +84.03%
2019-12-31 €385.98 Million
≈ $451.25 Million
€52.02 Million
≈ $60.82 Million
0.135x +29.18%
2018-12-31 €363.08 Million
≈ $424.48 Million
€37.88 Million
≈ $44.29 Million
0.104x -15.03%
2017-12-31 €335.73 Million
≈ $392.50 Million
€41.23 Million
≈ $48.20 Million
0.123x -10.05%
2016-12-31 €316.48 Million
≈ $369.99 Million
€43.20 Million
≈ $50.51 Million
0.137x +1.61%
2015-12-31 €289.49 Million
≈ $338.45 Million
€38.90 Million
≈ $45.47 Million
0.134x -12.68%
2014-12-31 €268.40 Million
≈ $313.78 Million
€41.30 Million
≈ $48.28 Million
0.154x +29.18%
2013-12-31 €235.96 Million
≈ $275.86 Million
€28.11 Million
≈ $32.86 Million
0.119x -20.61%
2012-12-31 €228.01 Million
≈ $266.57 Million
€34.21 Million
≈ $39.99 Million
0.150x +5.70%
2011-12-31 €211.29 Million
≈ $247.02 Million
€29.99 Million
≈ $35.06 Million
0.142x -23.87%
2010-12-31 €184.27 Million
≈ $215.43 Million
€34.36 Million
≈ $40.17 Million
0.186x -27.85%
2009-12-31 €154.95 Million
≈ $181.15 Million
€40.05 Million
≈ $46.82 Million
0.258x +61.72%
2008-12-31 €137.05 Million
≈ $160.23 Million
€21.90 Million
≈ $25.61 Million
0.160x -45.09%
2007-12-31 €127.87 Million
≈ $149.49 Million
€37.22 Million
≈ $43.51 Million
0.291x +38.50%
2006-12-31 €111.15 Million
≈ $129.94 Million
€23.36 Million
≈ $27.31 Million
0.210x -39.22%
2005-12-31 €86.82 Million
≈ $101.50 Million
€30.01 Million
≈ $35.09 Million
0.346x +19.09%
2004-12-31 €71.38 Million
≈ $83.45 Million
€20.72 Million
≈ $24.23 Million
0.290x --

About Vetoquinol

PA:VETO France Drug Manufacturers - Specialty & Generic
Market Cap
$972.53 Million
€831.86 Million EUR
Market Cap Rank
#9080 Global
#145 in France
Share Price
€70.50
Change (1 day)
-0.70%
52-Week Range
€67.20 - €91.00
All Time High
€149.34
About

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal … Read more